Fool.com contributor Parkev Tatevosian reviews Pfizer (PFE 0.65%) stock for passive income investors.
*Stock prices used were the afternoon prices of May 28, 2024. The video was published on May 30, 2024.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?
By Parkev Tatevosian, CFA
–
May 31, 2024 at 3:30AM
NYSE: PFE
Pfizer
Market Cap
$159B
Today's Change
(0.65%) $0.18
Current Price
$27.98
Price as of June 28, 2024, 4:00 p.m. ET
Pfizer's dividend yield is rising as the stock price is falling.
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pfizer. The Motley Fool has a disclosure policy.
Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.